Akero Therapeutics Ownership | Who Owns Akero Therapeutics?

Overview Forecast RevenueFinancials Chart

Akero Therapeutics Ownership Summary

Akero Therapeutics is owned by 105.12% institutional investors, 5.34% insiders. Janus henderson group is the largest institutional shareholder, holding 11.59% of AKRO shares. Vanguard Health Care Inv is the top mutual fund, with 6.34% of its assets in Akero Therapeutics shares.

AKRO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Akero Therapeutics	105.12%	5.34%	-10.46%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Janus henderson group	6.88M	11.59%	$161.28M
Blackrock	5.59M	9.42%	$131.06M
Rtw investments, lp	5.43M	9.16%	$127.43M
General atlantic	5.23M	8.83%	$122.79M
Wellington management group llp	5.11M	8.62%	$119.99M
Price t rowe associates inc /md/	4.15M	6.99%	$97.28M
Vanguard group	3.71M	6.25%	$86.92M
Alkeon capital management	3.33M	5.61%	$78.06M
State street	2.69M	4.53%	$63.09M
Alliancebernstein	1.91M	3.22%	$44.76M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
University of wisconsin foundation	423.85K	11.19%	$9.94M
Propel bio management	327.75K	4.99%	$7.69M
General atlantic	5.23M	3.86%	$122.79M
Silverarc capital management	625.09K	3.46%	$14.66M
Yiheng capital management	1.43M	2.71%	$33.65M
Redmile group	1.61M	2.29%	$37.88M
Boxer capital	1.68M	2.07%	$39.34M
Rtw investments, lp	5.43M	1.97%	$127.43M
Logos global management lp	800.00K	1.51%	$18.77M
Bioimpact capital	385.99K	1.41%	$9.06M

Top Buyers

Holder	Shares	% Assets	Change
Janus henderson group	6.88M	0.09%	754.28K
Blackrock	5.59M	0.00%	694.02K
T. rowe price investment management	1.77M	0.03%	665.19K
Morgan stanley	946.53K	0.00%	542.66K
Long focus capital management	719.60K	0.65%	391.00K

Top Sellers

Holder	Shares	% Assets	Change
Baker bros. advisors lp	1.10M	0.33%	-1.62M
Fred alger management	123.79K	0.01%	-1.21M
State street	2.69M	0.00%	-1.11M
Braidwell lp	-	-	-1.08M
Artisan partners limited partnership	-	-	-303.92K

New Positions

Holder	Shares	% Assets	Change	Value
Rheos capital works	216.00K	0.27%	216.00K	$5.07M
Corebridge financial	36.47K	0.00%	36.47K	$855.66K
Mirae asset global etfs	35.47K	0.00%	35.47K	$831.83K
Trexquant investment lp	24.65K	0.01%	24.65K	$578.31K
Two sigma advisers, lp	18.10K	0.00%	18.10K	$424.63K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-12.00
Riggs asset managment	-14.00
Ica group wealth management	-110.00
Pacer advisors	-688.00
Banque cantonale vaudoise	-1.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	180	14.65%	72,997,386	1.71%	105	0.72%	85	8.97%	57	7.55%
Jun 30, 2024	157	-15.14%	71,768,872	-1.77%	121	0.80%	78	-29.09%	53	12.77%
Mar 31, 2024	185	8.82%	73,065,461	23.85%	123	1.10%	110	25.00%	47	-2.08%
Dec 31, 2023	170	-21.30%	58,992,846	3.30%	105	1.00%	88	-29.60%	48	29.73%
Sep 30, 2023	216	22.03%	57,109,194	0.85%	102	0.86%	125	26.26%	37	-5.13%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	4.40M	6.34%	2.86M
Janus Henderson Global Life Sciences D	2.04M	2.94%	-1.41K
Janus Henderson Global Life Sciences	2.01M	2.89%	-118.09K
Vanguard Total Stock Mkt Idx Inv	1.93M	2.76%	-14.72K
US Small-Cap Growth II Equity Comp	1.81M	2.61%	-181.25K
T. Rowe Price New Horizons	1.81M	2.61%	-5.72K
iShares Russell 2000 ETF	1.74M	2.50%	-3.92K
Janus Henderson Glb Life Scn I2 USD	1.50M	2.15%	6.88K
Janus Global Life Science AUSD	1.50M	2.14%	-51.08K
SPDR® S&P Biotech ETF	997.09K	1.44%	11.02K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 10, 2024	Rolph Timothy	Chief Scientific Officer	Sell	$76.02K
Dec 10, 2024	Rolph Timothy	Chief Scientific Officer	Sell	$72.91K
Dec 10, 2024	Young Jonathan	Chief Operating Officer	Sell	$77.07K
Dec 10, 2024	Lamy Patrick	Senior VP, Commercial Strategy	Sell	$28.48K
Dec 10, 2024	Yale Catriona	Chief Development Officer	Sell	$86.52K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	28
2024 Q3	-	26
2024 Q2	-	10
2024 Q1	-	12
2023 Q4	4	16

AKRO Ownership FAQ

Who Owns Akero Therapeutics?

Akero Therapeutics shareholders are primarily institutional investors at 105.12%, followed by 5.34% insiders and -10.46% retail investors. The average institutional ownership in Akero Therapeutics's industry, Biotech Stocks , is 47.04%, which Akero Therapeutics exceeds.

Who owns the most shares of Akero Therapeutics?

Akero Therapeutics’s largest shareholders are Janus henderson group (6.88M shares, 11.59%), Blackrock (5.59M shares, 9.42%), and Rtw investments, lp (5.43M shares, 9.16%). Together, they hold 30.17% of Akero Therapeutics’s total shares outstanding.

Does Blackrock own Akero Therapeutics?

Yes, BlackRock owns 9.42% of Akero Therapeutics, totaling 5.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 131.06M$. In the last quarter, BlackRock increased its holdings by 694.02K shares, a 14.19% change.

Who is Akero Therapeutics’s biggest shareholder by percentage of total assets invested?

University of wisconsin foundation is Akero Therapeutics’s biggest shareholder by percentage of total assets invested, with 11.19% of its assets in 423.85K Akero Therapeutics shares, valued at 9.94M$.

Who is the top mutual fund holder of Akero Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Akero Therapeutics shares, with 6.34% of its total shares outstanding invested in 4.4M Akero Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools